Induction of apoptosis and inhibition of c-erbB-2 in breast cancer cells by flavopiridol

Clinical Cancer Research

Volumn 6, Issue 1, 2000, Pages 223-229

  Li, Yiwei ^a   Bhuiyan, Mahbubur ^a   Alhasan, Samir ^a   Senderowicz, Adrian M ^b   Sarkar, Fazlul H ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; FLAVOPIRIDOL; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CANCER INVASION; CONTROLLED STUDY; DRUG EFFECT; ENZYME REPRESSION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; ONCOGENE C ERB; PRIORITY JOURNAL; ZYMOGRAPHY;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CASPASE 3; CASPASES; ENZYME PRECURSORS; FEMALE; FLAVONOIDS; GENES, ERBB-2; HUMANS; MATRIX METALLOPROTEINASES; MICE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PIPERIDINES; POLY(ADP-RIBOSE) POLYMERASES; RECEPTOR, ERBB-2; RECOMBINANT PROTEINS; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 0033960068     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Carlson, B. A., Dubay, M. M., Sausville, E. A., Brizuela, L., and Worland, P. J. Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells. Cancer Res., 56: 2973-2978, 1996.
2. Sedlacek, H., Czech, J., Naik, R., Kaur, G., Worland, P., Losiewicz, M., Parker, B., Carlson, B., Smith, A., Senderowicz, A. M., and Sausville, E. A. Flavopiridol (L86-8275, NSC 649890), a new kinase inhibitor for tumor therapy. Int. J. Oncol., 9: 1143-1168, 1996.
3. Jager, W., Zembsch, B., Wolschann, P., Pittenauer, E., Senderowicz, A. M., Sausville, E. A., Sedlacek, H. H., Graf, J., and Thalhammer, T. Metabolism of the anticancer drug flavopiridol, a new inhibitor of cyclin dependent kinases, in rat liver. Life Sci., 62: 1861-1873, 1998.
4. Stinson, S. F., Hill, K., Siford, T. J., Phillips, L. R., and Daw, T. W. Determination of flavopiridol (L86 8275; NSC 649890) in human plasma by reversed-phase liquid chromatography with electrochemical detection. Cancer Chemother. Pharmacol., 42: 261-265, 1998.
5. Arguello, F., Alexander, M., Sterry, J. A., Tudor, G., Smith, E. M., Kalavar, N. T., Greene, J. F., Jr., Koss, W., Morgan, C. D., Stinson, S. F., Siford, T. J., Alvord, W. G., Klabansky, R. L., and Sausville, E. A. Flavopiridol induces apoptosis of normal lymphoid cells, causes immunosuppression, and has potent antitumor activity in vivo against human leukemia and lymphoma xenografts. Blood, 91: 2482-2490, 1998.
6. Bible, K. C., and Kaufmann, S. H. Cytotoxic synergy between flavopiridol (NSC 649890, L86-8275) and various antineoplastic agents: the importance of sequence of administration. Cancer Res., 57: 3375-3380, 1997.
7. Senderowicz, A. M., Headlee, D., Stinson, S. F., Lush, R. M., Kalil, N., Villalba, L., Hill, K., Steinberg, S. M., Figg, W. D., Tompkins, A., Arbuck, S. G., and Sausville, E. A. Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasms. J. Clin. Oncol., 16: 2986-2999, 1998.
8. Chiarugi, V., Magnelli, L., Cinelli, M., and Basi, G. Apoptosis and the cell cycle. Cell. Mol. Biol. Res., 40: 603-612, 1994.
9. Sedlak, M. L., Oltvai. Z. N., Yang, E., Wan, g K., Boise, L. H., and Thompson, C. B. Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. Proc. Natl. Acad. Sci., 92: 7934-7938, 1995.
10. Salomons, G. S., Brady, H. J., Verwijs-Janssen, M., Van, J. D., Hart, A. A., Van, H., Behren, K., and Smets, L. A. The Bax α:Bcl-2 ratio modulates the response to dexamethasone in leukaemic cells and is highly variable in childhood acute leukaemia. Int. J. Cancer, 71: 959-965, 1997.
11. American Cancer Society. Cancer facts and figures 1998. American Cancer Atlanta: Society Inc., 1998.
12. Lacroix, H., Iglehart, J. D., Skinner, M. A., and Kraus, M. H. Overexpression of erbB-2 or EGF receptor proteins present in early stage mammary carcinoma is detected simultaneously in matched primary tumors and regional metastases. Oncogene, 4: 145-151, 1989.
13. Yu, D., Wang, S. S., Dulski, K. M., Tsai, C. M., Nicolson, G. L., and Hung, M. C. c-erbB-2/neu overexpression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties. Cancer Res., 54: 3260-3266, 1994.
14. Tan, M., Yao, J., and Yu, D. Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities. Cancer Res., 57: 1199-1205, 1997.
15. Liotta, L. A., and Stetler, S. W. Metalloproteinases and cancer invasion. Semin. Cancer Biol., 1: 99-106, 1990.
16. Liotta, L. A., Steeg, P. S., and Stetler, S. W. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell, 64: 327-336, 1991.
17. Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., and Yamamoto, E. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature (Lond.), 370: 61-65, 1994.
18. Yu. D., Liu, B., Tan, M., Li, J., Wang, S. S., and Hung, M. C. Overexpression of c-erbB-2/neu in breast cancer cells confers increased resistance to Taxol via mdr-1-independent mechanisms. Oncogene. 13: 1359-1365, 1996.
19. Muller, D., Breathnach, R., Engelmann, A., Millon, R., Bronner, G., and Flesch, H. Expression of collagenase-related metalloproteinase genes in human lung or head and neck tumours. Int. J. Cancer. 48: 550-556, 1991.
20. Parker, B. W., Kaur, G., Nieves-Neira, W., Taimi, M., Kohlhagen, G., Shimizu, T., Losiewicz, M. D., Pommier, Y., Sausville, E. A., and Senderowicz, A. M. Early induction of apoptosis in hematopoietic cell lines after exposure to flavopiridol. Blood, 91: 458-465. 1998.
21. Konig, A., Schwartz, G. K., Mohammad, R. M., Al-Katib, A., and Gabrilove, J. L. The novel cyclin-dependent kinase inhibitor flavopiridol down-regulates Bcl-2 and induces growth arrest and apoptosis in chronic B-cell leukemia lines. Blood, 90: 4307-4312, 1997.
22. Huang, P., Ballal, K., and Plunkett, W. Biochemical characterization of the protein activity responsible for high molecular weight DNA fragmentation during drug-induced apoptosis. Cancer Res., 57: 3407-3414, 1997.
23. Byrd, J. C., Shinn, C., Waselenko, J. K., Fuchs, E. J., Lehman, T. A., Nguyen, P. L., Flinn, I. W., Diehl, L. F., Sausville, E., and Grever, M. R. Flavopiridol induces apoptosis in chronic lymphocytic leukemia cells via activation of caspase-3 without evidence of bcl-2 modulation or dependence on functional p53. Blood, 92: 3804-3816, 1998.
24. Darmon, A. J., Nicholson, D. W., and Bleackley, R. C. Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B. Nature (Lond.), 377: 446-448, 1995.
25. Li, Y., Bhuiyan, M., Mohammad, R. M., and Sarkar, F. H. Induction of apoptosis in breast cancer cells by TPA. Oncogene, 17: 2915-2920, 1998.
26. Patel, V., Senderowicz, A. M., Pinto, D. Jr., Igishi, T., Raffeld, M., Quintanilla-Martinez, L., Ensley, J. F., Sausville, E. A., and Gutkind, J. S. Flavopiridol, a novel cyclin-dependent kinase inhibitor, suppresses the growth of head and neck squamous cell carcinomas by inducing apoptosis. J. Clin. Invest., 102: 1674-1681, 1998.
27. Bible, K. C., and Kaufmann, S. H. Flavopiridol: a cytotoxic flavone that induces cell death in noncycling A549 human lung carcinoma cells. Cancer Res., 50: 4856-4861, 1996.
28. Brusselbach, S., Nettelbeck, D. M., Sedlacek, H. H., and Muller, R. Cell cycle-independent induction of apoptosis by the anti-tumor drag flavopiridol in endothelial cells. Int. J. Cancer, 77: 146-152, 1998.
29. Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., and McGuire, W. L. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science (Washington DC), 235: 177-182, 1987.
30. Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., Levin, J., Stuart, S. G., Udove, J., Ullrich, A., and McGuire, W. L. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science (Washington DC), 244: 707-712, 1989.